Dubai – AGBL West Africa announced the successful installation of the first high-throughput Next Generation Sequencing system platform at the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) in Nigeria.
Mr. Mohamed Ben Marzouk, a senior Area Manager at AGBL Afrique, said, “We are proud to have completed the very first installation successfully at ACEGID, Redeemers University in Nigeria. This sequencing platform will greatly enhance ACEGID’s sequencing capabilities, helping them to work with genomes of animals and human in a flexible, scalable more economical manner. This portends immense potential in Africa’s public health through empowering Genomics research and evidence based public health policies in Africa.”
About AGBL West Africa
AGBL West Africa is a member of the AGBL group of companies, the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centres in emerging healthcare markets. AGBL West Africa is headquartered in Accra, Ghana, with branches and field staff across Nigeria and West Africa.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
